Genomic instability in breast and ovarian cancers: translation into clinical predictive biomarkers (Q37933098)

25 August 2017

1 reference

title

Genomic instability in breast and ovarian cancers: translation into clinical predictive biomarkers (English)

1 reference

25 August 2017

0 references

1 reference

Marieke A Vollebergh

1

1 reference

25 August 2017

Jos Jonkers

series ordinal

2

1 reference

25 August 2017

Sabine C Linn

series ordinal

3

1 reference

25 August 2017

publication date

16 September 2011

1 reference

Cellular and Molecular Life Sciences

25 August 2017

published in

1 reference

25 August 2017

volume

69

1 reference

25 August 2017

issue

2

1 reference

25 August 2017

page(s)

223-245

1 reference

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Targeting poly(ADP-ribose) polymerase: a two-armed strategy for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Current development of clinical inhibitors of poly(ADP-ribose) polymerase in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

BRCA1 mutations in primary breast and ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Identification of the breast cancer susceptibility gene BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Prognostic Relevance of Uncommon Ovarian Histology in Women With Stage III/IV Epithelial Ovarian Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Diverse tumorigenic pathways in ovarian serous carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

ARID1A mutations in endometriosis-associated ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Alternate molecular genetic pathways in ovarian carcinomas of common histological types.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Lack of effective systemic therapy for recurrent clear cell carcinoma of the ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

DNA copy numbers profiles in affinity-purified ovarian clear cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

21 January 2018

TP53 and breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

p53 gene mutations and protein accumulation in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

High frequency of TP53 mutation in BRCA1 and sporadic basal-like carcinomas but not in BRCA1 luminal breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Meta-analysis of BRCA1 and BRCA2 penetrance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Cancer risks in BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Cancer Incidence in BRCA1 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Chromosomal stability and the DNA double-stranded break connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Concerning the origin of malignant tumours by Theodor Boveri. Translated and annotated by Henry Harris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Genome maintenance mechanisms for preventing cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Mechanisms of double-strand break repair in somatic mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

DNA repair in mammalian cells: DNA double-strand break repair: how to fix a broken relationship.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Multiple functions of MRN in end-joining pathways during isotype class switching

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

BRCA1 and its toolbox for the maintenance of genome integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

The Fanconi Anemia/BRCA pathway: new faces in the crowd

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Disorders of nucleotide excision repair: the genetic and molecular basis of heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Defective transcription-coupled repair in Cockayne syndrome B mice is associated with skin cancer predisposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Genetic instabilities in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Base-excision repair of oxidative DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Nitrogen mustard- and half-mustard-induced damage in Escherichia coli requires different DNA repair pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Impairment of APE1 function enhances cellular sensitivity to clinically relevant alkylators and antimetabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Is base excision repair a tumor suppressor mechanism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Coordination of DNA mismatch repair and base excision repair processing of chemotherapy and radiation damage for targeting resistant cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Base excision repair is impaired in mammalian cells lacking Poly(ADP-ribose) polymerase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Requirement for the Xrcc1 DNA base excision repair gene during early mouse development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Inherited variants of MYH associated with somatic G:C-->T:A mutations in colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

The multifaceted mismatch-repair system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Mismatch repair deficient colorectal cancer in the era of personalized treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Meiotic pachytene arrest in MLH1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Hypermutability and mismatch repair deficiency in RER+ tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Methotrexate induces oxidative DNA damage and is selectively lethal to tumour cells with defects in the DNA mismatch repair gene MSH2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

A high-throughput pharmaceutical screen identifies compounds with specific toxicity against BRCA2-deficient tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

DNA polymerases as potential therapeutic targets for cancers deficient in the DNA mismatch repair proteins MSH2 or MLH1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

DNA double-strand breaks associated with replication forks are predominantly repaired by homologous recombination involving an exchange mechanism in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Hallmarks of 'BRCAness' in sporadic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Integrated genomic analyses of ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

The FA/BRCA pathway is involved in melphalan-induced DNA interstrand cross-link repair and accounts for melphalan resistance in multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Biallelic inactivation of BRCA2 in Fanconi anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Chromosome breakage syndromes and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Recombinational DNA repair and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Genetic heterogeneity among Fanconi anemia heterozygotes and risk of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

The BRCA1 suppressor hypothesis: An explanation for the tissue-specific tumor development in BRCA1 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Estrogen receptor alpha is a putative substrate for the BRCA1 ubiquitin ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Negative feedback loop of BRCA1-BARD1 ubiquitin ligase on estrogen receptor alpha stability and activity antagonized by cancer-associated isoform of BARD1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Estrogen receptor (ER) beta or p53 attenuates ERalpha-mediated transcriptional activation on the BRCA2 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Increased progesterone receptor expression in benign epithelium of BRCA1-related breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Long-range transcriptional control of progesterone receptor gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

BRCA2 cooperates with histone acetyltransferases in androgen receptor-mediated transcription.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Androgen pathway dysregulation in BRCA1-mutated breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Cancer incidence and mortality in men with Klinefelter syndrome: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Etiologic factors for male breast cancer in the U.S. Veterans Affairs medical care system database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Cancer incidence in women with Turner syndrome in Great Britain: a national cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

BRCA1 supports XIST RNA concentration on the inactive X chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

X chromosomal abnormalities in basal-like human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

BRCA1 foci in normal S-phase nuclei are linked to interphase centromeres and replication of pericentric heterochromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

BRCA1 does not paint the inactive X to localize XIST RNA but may contribute to broad changes in cancer that impact XIST and Xi heterochromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Clinical trial designs for predictive marker validation in cancer treatment trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Effect of BRCA Mutations on the Length of Survival in Epithelial Ovarian Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

The usefulness of antibodies to the BRCA1 protein in detecting the mutated BRCA1 gene. An immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Cyclophosphamide dose intensification may circumvent anthracycline resistance of p53 mutant breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Increased expression of BRCA1 mRNA predicts favorable response to anthracycline-containing chemotherapy in breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

The prognostic value of BRCA1 mRNA expression levels following neoadjuvant chemotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

BRCA1 mRNA expression levels predict for overall survival in ovarian cancer after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

The DNA repair proteins BRCA1 and ERCC1 as predictive markers in sporadic ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

DNA repair signature is associated with anthracycline response in triple negative breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Smart bombs versus blunderbusses: high-dose chemotherapy for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Eleven years disease-free: role of chemotherapy in metastatic BRCA2-related breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

BRCA1 interacts with components of the histone deacetylase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Methylation is less abundant in BRCA1-associated compared with sporadic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian tumors with low malignant potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Intact Mre11/Rad50/Nbs1 complex predicts good response to radiotherapy in early breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Promoter hypermethylation of FANCF plays an important role in the occurrence of ovarian cancer through disrupting Fanconi anemia-BRCA pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Promoter hypermethylation of FANCF and outcome in advanced ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Association between excision repair cross-complementation group 1 polymorphism and clinical outcome of platinum-based chemotherapy in patients with epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

The relationship of platinum resistance and ERCC1 protein expression in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

ERCC5 is a novel biomarker of ovarian cancer prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Human apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastro-oesophageal and pancreatico-biliary cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Polymorphism of the DNA repair enzyme XRCC1 is associated with treatment prediction in anthracycline and cyclophosphamide/methotrexate/5-fluorouracil-based chemotherapy of patients with primary invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Polymorphisms in XRCC1, XRCC3, and CCND1 and survival after treatment for metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Loss of hMLH1 expression correlates with improved survival in stage III-IV ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

The acquisition of hMLH1 methylation in plasma DNA after chemotherapy predicts poor survival for ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Microsatellite instability predicts poor short-term survival in patients with advanced breast cancer after high-dose chemotherapy and autologous stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Mismatch repair and treatment resistance in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

The expression of mismatched repair genes and their correlation with clinicopathological parameters and response to neo-adjuvant chemotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Cross-species comparison of aCGH data from mouse and human BRCA1- and BRCA2-mutated breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Recurrent copy number alterations in BRCA1-mutated ovarian tumors alter biological pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Advances in understanding cancer genomes through second-generation sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Complex landscapes of somatic rearrangement in human breast cancer genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Somatic structural rearrangements in genetically engineered mouse mammary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Utility of DNA repair protein foci for the detection of putative BRCA1 pathway defects in breast cancer biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Prediction of breast cancer sensitivity to neoadjuvant chemotherapy based on status of DNA damage repair proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Development of a functional assay for homologous recombination status in primary cultures of epithelial ovarian tumor and correlation with sensitivity to poly(ADP-ribose) polymerase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

A marker of homologous recombination predicts pathologic complete response to neoadjuvant chemotherapy in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Resistance to therapy caused by intragenic deletion in BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0809-0

Response to a third-line mitomycin C (MMC)-based chemotherapy in a patient with metastatic pancreatic adenocarcinoma carrying germline BRCA2 mutation

21 January 2018

1 reference

12 December 2020

Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy

1 reference

12 December 2020

Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas

1 reference

12 December 2020

Expression of factors involved in regulation of DNA mismatch repair- and apoptosis pathways in ovarian cancer patients.

1 reference

12 December 2020

p53 mutations and expression in ovarian cancers: correlation with overall survival

1 reference

12 December 2020

The BRCA1/BRCA2/Rad51 complex is a prognostic and predictive factor in early breast cancer

1 reference

12 December 2020

Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH

1 reference

12 December 2020

Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium

1 reference

12 December 2020

Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer

1 reference

12 December 2020

Hormone replacement and the risk of breast cancer in Turner's syndrome

1 reference

12 December 2020

Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer.

1 reference

12 December 2020

Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas

1 reference

12 December 2020

Failure of BRCA1 dysfunction to alter ovarian cancer survival.

1 reference

12 December 2020

Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer

1 reference

12 December 2020

Variation in BRCA1 cancer risks by mutation position

1 reference

12 December 2020

An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients

1 reference

12 December 2020

Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor.

1 reference

12 December 2020

Patterns and incidence of chromosomal instability and their prognostic relevance in breast cancer subtypes.

1 reference

12 December 2020

A predictor based on the somatic genomic changes of the BRCA1/BRCA2 breast cancer tumors identifies the non-BRCA1/BRCA2 tumors with BRCA1 promoter hypermethylation

1 reference

12 December 2020

BRCA1 Inhibition of Estrogen Receptor Signaling in Transfected Cells

1 reference

12 December 2020

CpG Island Methylation of DNA Damage Response Genes in Advanced Ovarian Cancer

1 reference

12 December 2020

Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer

1 reference

12 December 2020

Mouse model for the DNA repair/basal transcription disorder trichothiodystrophy reveals cancer predisposition.

1 reference

12 December 2020

Utility of gene promoter methylation in prediction of response to platinum-based chemotherapy in epithelial ovarian cancer (EOC)

1 reference

12 December 2020

Effect of bilateral oophorectomy on mammary tumor formation in BRCA1 mutant mice

1 reference

12 December 2020

The disappearing Barr body in breast and ovarian cancers

1 reference

12 December 2020

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy

1 reference

12 December 2020

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

12 December 2020

Therapeutic options for triple-negative breast cancers with defective homologous recombination

1 reference

12 December 2020

Inhibition of base excision repair potentiates iododeoxyuridine-induced cytotoxicity and radiosensitization

1 reference

12 December 2020

Reduced MLH1 expression in breast tumors after primary chemotherapy predicts disease-free survival

1 reference

12 December 2020

Increased mRNA levels of xeroderma pigmentosum complementation group B (XPB) and Cockayne's syndrome complementation group B (CSB) without increased mRNA levels of multidrug-resistance gene (MDR1) or metallothionein-II (MT-II) in platinum-resistant

1 reference

12 December 2020

Loss of DNA mismatch repair in acquired resistance to cisplatin

1 reference

12 December 2020

BRCA1 promoter methylation predicts adverse ovarian cancer prognosis

1 reference

12 December 2020

Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours

1 reference

12 December 2020

Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience

1 reference

12 December 2020

Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH

1 reference

12 December 2020

Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma

1 reference

12 December 2020

Indicators of homologous recombination deficiency in breast cancer and association with response to neoadjuvant chemotherapy.

1 reference

12 December 2020

10.1007/S00018-011-0809-0

Identifiers

DOI

1 reference

release_nmrcsxpw3be43jpzorxc4kad54

25 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nmrcsxpw3be43jpzorxc4kad54

24 November 2022

mapped directly with Wikidata item

1 reference